Federal judge pauses Louisiana telehealth abortion suit pending FDA review

After the Trump administration appealed, a federal judge put on pause a lawsuit filed by the state of Louisiana that challenges the federal policy of allowing mail-order abortion pills.

U.S. District Judge David Joseph in Lafayette, Louisiana, ruled that the challenge be paused pending the U.S. Food and Drug Administration (FDA)’s review of the safety of the drug but noted that the state could continue the challenge after the review was completed.

Louisiana Attorney General Liz Murrill filed a lawsuit in late 2025 to challenge the 2023 deregulation of mifepristone, which is used in chemical abortions. The 2023 rule changes, initiated during former president Joe Biden’s administration, allowed the drugs to be delivered through the mail and prescribed without any visits to a doctor.

In January of this year, President Donald Trump’s Department of Justice (DOJ) filed a motion with a federal district court to pause the suit, pending a review by the FDA of the chemical abortion drug.